ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,666 | -98.2% | 12,641 | -91.0% | 0.00% | – |
| Q4 2022 | $91,652 | -33.6% | 141,198 | +26.5% | 0.00% | – |
| Q2 2022 | $138,000 | +626.3% | 111,647 | +289.7% | 0.00% | – |
| Q1 2022 | $19,000 | -75.6% | 28,648 | -59.9% | 0.00% | – |
| Q4 2021 | $78,000 | -37.6% | 71,510 | +4.2% | 0.00% | – |
| Q3 2021 | $125,000 | -74.5% | 68,622 | -63.0% | 0.00% | – |
| Q2 2021 | $491,000 | -31.4% | 185,705 | -6.6% | 0.00% | – |
| Q1 2021 | $716,000 | +704.5% | 198,880 | +462.8% | 0.00% | – |
| Q4 2020 | $89,000 | -71.7% | 35,340 | -71.6% | 0.00% | – |
| Q3 2020 | $314,000 | -29.6% | 124,383 | -8.5% | 0.00% | – |
| Q2 2020 | $446,000 | +913.6% | 136,006 | +651.0% | 0.00% | – |
| Q1 2020 | $44,000 | -67.6% | 18,111 | -37.0% | 0.00% | – |
| Q4 2019 | $136,000 | -69.9% | 28,741 | -72.8% | 0.00% | – |
| Q3 2019 | $452,000 | +117.3% | 105,718 | -5.0% | 0.00% | – |
| Q4 2018 | $208,000 | +29.2% | 111,224 | +121.5% | 0.00% | – |
| Q3 2018 | $161,000 | +114.7% | 50,212 | +162.9% | 0.00% | – |
| Q1 2018 | $75,000 | +70.5% | 19,100 | +78.2% | 0.00% | – |
| Q4 2017 | $44,000 | -74.6% | 10,717 | -61.9% | 0.00% | -100.0% |
| Q3 2017 | $173,000 | -75.2% | 28,115 | -74.9% | 0.00% | -50.0% |
| Q2 2017 | $698,000 | +35.8% | 112,200 | +38.4% | 0.00% | 0.0% |
| Q1 2017 | $514,000 | -18.8% | 81,045 | -31.4% | 0.00% | -33.3% |
| Q4 2016 | $633,000 | +244.0% | 118,200 | +260.9% | 0.00% | +200.0% |
| Q3 2016 | $184,000 | -51.1% | 32,748 | -52.2% | 0.00% | 0.0% |
| Q2 2016 | $376,000 | -53.8% | 68,557 | -37.4% | 0.00% | -80.0% |
| Q1 2016 | $813,000 | -26.0% | 109,539 | -17.2% | 0.01% | -16.7% |
| Q4 2015 | $1,099,000 | -16.4% | 132,233 | -9.4% | 0.01% | -33.3% |
| Q3 2015 | $1,314,000 | -25.3% | 145,907 | -0.5% | 0.01% | -25.0% |
| Q2 2015 | $1,759,000 | -45.7% | 146,586 | -51.2% | 0.01% | -52.0% |
| Q1 2015 | $3,237,000 | +7427.9% | 300,540 | +1730.3% | 0.02% | – |
| Q3 2014 | $43,000 | -15.7% | 16,420 | +30.7% | 0.00% | -100.0% |
| Q2 2014 | $51,000 | – | 12,567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |